Hyperkalemia Sequelae in Patients With Chronic Kidney Disease, Heart Failure, Neither or Both: Findings From the TRACK Study
Por:
Hsia, J, Chen, H, Shivappa, N, Winkelmayer, W, Tangri, N, Sundin, AK, Schneider, MP, Bover, J, Fried, L, Ferraro, PM, Butler, J, Bishop, M, Bakhai, A and Bonaca, M
Publicada:
4 nov 2025
Resumen:
Filiaciones:
Hsia, J:
Univ Colorado, Aurora, CO USA
Chen, H:
AstraZeneca, Wilmington, DE USA
Shivappa, N:
AstraZeneca, Wilmington, DE USA
Winkelmayer, W:
Baylor Coll Med, Houston, TX USA
Tangri, N:
Univ Manitoba, Winnipeg, MB, Canada
Sundin, AK:
AstraZeneca, Wilmington, DE USA
Schneider, MP:
Univ Erlangen Nurnberg, Nurnberg, Germany
:
Hosp Univ Germans Trias, Badalona, Spain
Fried, L:
Univ Pittsburgh, Pittsburgh, PA USA
Ferraro, PM:
Univ Verona, Verona, Italy
Butler, J:
Baylor Scott & White Res, Dallas, TX USA
Bishop, M:
AstraZeneca, Gaithersburg, MD USA
Bakhai, A:
Royal Free NHS, London, England
Bonaca, M:
CPC Clin Res, Aurora, CO USA
|